Production (Stage)
Lipocine Inc.
LPCN
$3.17
$0.0481.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -153.08% | 178.09% | 66.64% | 13.53% | 190.79% |
| Total Depreciation and Amortization | 83.53% | 95.00% | 10.39% | 4.94% | 77.08% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 116.95% | 89.61% | -106.69% | 91.78% | 56.76% |
| Change in Net Operating Assets | 87.23% | -115.35% | -139.52% | 64.48% | -1,028.60% |
| Cash from Operations | -181.80% | 184.16% | -8.71% | 24.53% | 161.29% |
| Capital Expenditure | -- | -8.70% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 78.43% | -71.81% | -11.30% | 33.48% | -173.57% |
| Cash from Investing | 78.43% | -72.09% | -17.74% | 33.48% | -173.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 255.77% | -35.00% |
| Cash from Financing | -- | 100.00% | -100.00% | 4,280.77% | -35.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -68.68% | 252.31% | -92.19% | 906.92% | -204.30% |